Novartis tests therapy for age-related muscle loss
The 7th TimePie Forum in Shanghai gathered 3,000 participants to discuss regenerative therapies from Novartis for muscle loss and osteoarthritis, alongside GLP-1 drug trials.
- Field
- ageing and longevity
- What they did
- At the TimePie forum, researchers gathered data on biological clocks, drugs for aging, and clinics studying aging processes.
- Why it matters
- This will help understand how aging biology relates to diseases and could become the basis for new treatment methods.
#timepie#novartis#glp-1#aging#clinical trial



